網頁

Wednesday, April 07, 2021

麻州擴大疫苗接種預先登記系統

麻州州長查理貝克(Charlie Baker)

            (Boston Orange編譯)麻州州長查理貝克(Charlie Baker)47日宣佈,擴大疫苗接種的預先登記系統,本週內將增加Amherst/Northampton,以及 Marshfield 2個區域合作疫苗接種站。

              419日起,麻州內的所有人都有資格接種新冠疫苗。查理貝克笑說,美國總統拜登(Biden)是跟尾麻州,也挑了這天做為所有人都有資格接種疫苗的日子。

           下週起,使用預先登記系統的人,將有機會先挑選接種疫苗地點,再挑選接種日期及時間。目前使用這預先登記系統只能從7個大型疫苗注射站挑選接種地點。希望在很快的未來,麻州內所有居民都可在距離自己5英里的範圍內找到疫苗接種站。

瑞維爾(Revere)市長Brian M. Arrigo。
             查理貝克7日參訪了瑞維爾(Revere)疫苗站後表示,迄今已有大約150萬人使用了預先登記系統,其中大約80萬人接到了有機會預約的通知。麻州政府將繼續改進預先登記系統,以期符合注射資格者上網預約時,整個流程更容易。

             查理貝克還說,要讓病毒大流行成為過去,接種疫苗明顯的很重要。麻州以受疫情影響最嚴重的耆英及有色社區為優先目標,已經用出去4百萬劑疫苗,大約150萬居民完整注射了疫苗。

                查理貝克認為,如果麻州能夠拿到更多,只需要注射一劑,保存條件不那麼嚴苛,二星期就可生效的強生(J&J)疫苗,麻州一定能更快達到全州居民都接種了新冠病毒疫苗的理想。

Baker-Polito Administration Announces Expansion of Preregistration System

REVERE — The Baker-Polito Administration announced today the expansion of the preregistration to include some regional collaboratives and improved features to allow for vaccination location selection during appointment booking.

Later this week, the Commonwealth’s preregistration system will expand to include the first regional collaboratives to the system. The Amherst/Northampton and Marshfield regional collaboratives will be the first to come online, and more regional collaboratives are working with the Command Center and tech teams to ensure they meet the operational and technological requirements to be added to the preregistration system.

Next week, the user experience for the preregistration system will change for people who are contacted with the opportunity to book appointments. People will have the opportunity to select their vaccination location before proceeding to select from available appointments.

To date, around 1.5 million people have preregistered using our system, with over 800,000 having been contacted with the opportunity to book appointments. We will continue to make improvements to the system in the weeks ahead, to make the process even easier as more people become eligible.

No comments:

Post a Comment